Q0237 Injection, tocilizumab-anoh, hospi
Also known as: Actemra, tocilizumab, IL-6 antagonist
Tocilizumab-anoh injection for hospital use, an interleukin-6 receptor antagonist monoclonal antibody used for rheumatoid arthritis and severe inflammatory conditions.
In Plain Language
inflammation fighter; arthritis injection
Clinical Context
Used for moderate to severe rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systemic sclerosis-associated interstitial lung disease. Hospital formulation used for inpatient administration.
RVU Information
CPT Q0237 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q0237?
CPT Q0237 (Injection, tocilizumab-anoh, hospi) is a Q Codes code. Tocilizumab-anoh injection for hospital use, an interleukin-6 receptor antagonist monoclonal antibody used for rheumatoid arthritis and severe inflammatory conditions.
Is Q0237 covered by insurance?
Q0237 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for moderate to severe rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systemic sclerosis-associated interstitial lung disease. Hospital formulation used for inpatient administration.
When is CPT Q0237 used?
Used for moderate to severe rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systemic sclerosis-associated interstitial lung disease. Hospital formulation used for inpatient administration.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.